BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3091271)

  • 1. Pertussigen enhances antigen-driven interferon-gamma production by sensitized lymphoid cells.
    Sewell WA; de Moerloose PA; McKimm-Breschkin JL; Vadas MA
    Cell Immunol; 1986 Feb; 97(2):238-47. PubMed ID: 3091271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.
    Sewell WA; Munoz JJ; Scollay R; Vadas MA
    J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines.
    Sewell WA; de Moerloose PA; Hamilton JA; Schrader JW; Mackay IR; Vadas MA
    Immunology; 1987 Aug; 61(4):483-8. PubMed ID: 3127325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice.
    Sewell WA; Munoz JJ; Vadas MA
    J Exp Med; 1983 Jun; 157(6):2087-96. PubMed ID: 6304228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussigen in vivo enhances antigen-specific production in vitro of lymphokine that stimulates macrophage procoagulant activity and plasminogen activator.
    de Moerloose PA; Hamilton JA; Sewell WA; Vadas MA; Mackay IR
    J Immunol; 1986 Dec; 137(11):3528-33. PubMed ID: 3782790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin.
    Mu HH; Sewell WA
    Immunology; 1994 Dec; 83(4):639-45. PubMed ID: 7875744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine lymph node antigen presenting cells are the main source of interleukin-6 in the initiation of delayed-type hypersensitivity.
    Ulrich P; Vohr HW
    Eur Cytokine Netw; 1996 Sep; 7(3):401-7. PubMed ID: 8954184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.
    Dhaliwal JS; Liew FY
    Infect Immun; 1987 Mar; 55(3):645-51. PubMed ID: 3818088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism by which pertussis toxin breaks unresponsiveness of delayed-type hypersensitivity to sheep red blood cells in mice.
    Tamura S; Tanaka H; Kikuta K; Kobayashi T; Sato H; Sato Y
    Cell Immunol; 1986 Jul; 100(2):351-63. PubMed ID: 3093086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
    Platzer E; Rubin BY; Lu L; Welte K; Broxmeyer HE; Moore MA
    J Immunol; 1985 Jan; 134(1):265-71. PubMed ID: 3917276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lymphocyte circulation in mice by pertussis toxin.
    Sewell WA; Andrews P
    Immunol Cell Biol; 1989 Oct; 67 ( Pt 5)():291-6. PubMed ID: 2613276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pertussis toxin (PT) on T-cell populations sensitized for delayed-type hypersensitivity in mice.
    Tamura SI; Nakanishi Y; Kojima A; Otokawa M; Uchida N; Sato H; Sato Y
    Cell Immunol; 1984 May; 85(2):351-63. PubMed ID: 6609000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activities of crystalline pertussigen from Bordetella pertussis.
    Munoz JJ; Arai H; Bergman RK; Sadowski PL
    Infect Immun; 1981 Sep; 33(3):820-6. PubMed ID: 6269999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pertussigen on inflammation caused by Freund adjuvant.
    Munoz JJ; Sewell WA
    Infect Immun; 1984 Jun; 44(3):637-41. PubMed ID: 6539301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector functions of long-term memory cells.
    Shive CL; Hofstetter H; Arredondo L; Shaw C; Forsthuber TG
    Eur J Immunol; 2000 Aug; 30(8):2422-31. PubMed ID: 10940934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma induction during oral tolerance reduces T-cell migration to sites of inflammation.
    Lee HO; Miller SD; Hurst SD; Tan LJ; Cooper CJ; Barrett TA
    Gastroenterology; 2000 Jul; 119(1):129-38. PubMed ID: 10889162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saponin adjuvant primes for a dominant interleukin-10 production to ovalbumin and to Trypanosoma cruzi antigen.
    Tadokoro CE; Macedo MS; Abrahamsohn IA
    Immunology; 1996 Nov; 89(3):368-74. PubMed ID: 8958049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed hypersensitivity induced by anti-T-cell-line antisera is enhanced by pertussigen and not restricted by histocompatibility genes.
    Gamble JR; Vadas MA; Munoz JJ; Thomas WR; Miller JF
    Proc Natl Acad Sci U S A; 1983 Apr; 80(7):2036-9. PubMed ID: 6300889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.